Literature DB >> 3133729

Osmotic diuresis.

F Lang1.   

Abstract

Osmotic diuresis occurs, if nonreabsorbed solutes such as mannitol impair the reabsorption of water. The reduced reabsorption of volume affects in turn the reabsorption and excretion of solutes. Thus, mannitol leads to modest impairment of proximal tubular reabsorption not only of water, but as well of electrolytes (Na, Cl, K, Pi, Ca, but not Mg), urea, and uric acid. Infusion of hypertonic mannitol increases renal blood flow and the glomerular filtration rate of superficial nephrons. The increased perfusion of medulla leads to wash out of medullary hypertonicity. The decline of medullary osmolarity leads to a marked impairment of water reabsorption in descending limbs and possibly to moderate impairment of NaCl, Ca, and Mg reabsorption in the ascending limbs of Henle's loop. In the collecting duct, inhibition is marked of water and urea reabsorption and modest of NaCl reabsorption. A number of open questions remain, such as the mechanisms underlying decrease of renal vascular resistance, increased proximal tubular reabsorption of magnesium, or impaired NaCl reabsorption in thick ascending limbs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3133729     DOI: 10.1159/000173127

Source DB:  PubMed          Journal:  Ren Physiol        ISSN: 0378-5858


  11 in total

Review 1.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Serum vasopressin (AVP) levels in polyuric brain-dead organ donors.

Authors:  M Hohenegger; M Vermes; W Mauritz; G Redl; P Sporn; P Eiselsberg
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

3.  Quantification and predictors of plasma volume expansion from mannitol treatment.

Authors:  P M Ambühl; P E Ballmer; S Krähenbühl; R Krapf
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

4.  SGK1-sensitive renal tubular glucose reabsorption in diabetes.

Authors:  Teresa F Ackermann; Krishna M Boini; Harald Völkl; Madhuri Bhandaru; Petra M Bareiss; Lothar Just; Volker Vallon; Kerstin Amann; Dietmar Kuhl; Yuxi Feng; Hans-Peter Hammes; Florian Lang
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

5.  Semi-mechanistic kidney model incorporating physiologically-relevant fluid reabsorption and transporter-mediated renal reabsorption: pharmacokinetics of γ-hydroxybutyric acid and L-lactate in rats.

Authors:  Rutwij A Dave; Marilyn E Morris
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-04       Impact factor: 2.745

6.  Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.

Authors:  Federico Pea; Elena Di Qual; Aldo Cusenza; Loris Brollo; Marco Baldassarre; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus.

Authors:  Jean M Whaley; Mark Tirmenstein; Timothy P Reilly; Simon M Poucher; Joanne Saye; Shamik Parikh; James F List
Journal:  Diabetes Metab Syndr Obes       Date:  2012-07-23       Impact factor: 3.168

8.  Prediction of neurologic deterioration based on support vector machine algorithms and serum osmolarity equations.

Authors:  Jixian Lin; Aihua Jiang; Meirong Ling; Yanqing Mo; Meiyi Li; Jing Zhao
Journal:  Brain Behav       Date:  2018-06-11       Impact factor: 2.708

9.  Plasma Hyperosmolality Prolongs QTc Interval and Increases Risk for Atrial Fibrillation in Traumatic Brain Injury Patients.

Authors:  Wojciech Dabrowski; Dorota Siwicka-Gieroba; Chiara Robba; Rafael Badenes; Mateusz Bialy; Paulina Iwaniuk; Todd T Schlegel; Andrzej Jaroszynski
Journal:  J Clin Med       Date:  2020-04-30       Impact factor: 4.241

Review 10.  A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease.

Authors:  Lucia Del Vecchio; Angelo Beretta; Carlo Jovane; Silvia Peiti; Simonetta Genovesi
Journal:  Drugs       Date:  2021-08-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.